Business Description
Metropolis Healthcare Ltd
ISIN : INE112L01020
Compare
Compare
Traded in other countries / regions
542650.India Index Membership
NIFTY 500 IPO Date
2019-04-15Description
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.01 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 0.57 | |||||
| Interest Coverage | 11.74 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 12.84 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -11.6 | |||||
| 3-Year FCF Growth Rate | -3.3 | |||||
| 3-Year Book Growth Rate | 15.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 28.12 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 15.05 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.27 | |||||
| 9-Day RSI | 34.98 | |||||
| 14-Day RSI | 34.85 | |||||
| 3-1 Month Momentum % | -16.1 | |||||
| 6-1 Month Momentum % | -16.02 | |||||
| 12-1 Month Momentum % | 12.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 51.3 | |||||
| Days Sales Outstanding | 35.42 | |||||
| Days Payable | 118.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -20.6 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.65 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.49 | |||||
| Operating Margin % | 17.43 | |||||
| Net Margin % | 11.56 | |||||
| FCF Margin % | 15.21 | |||||
| ROE % | 13.73 | |||||
| ROA % | 9.73 | |||||
| ROIC % | 12.48 | |||||
| 3-Year ROIIC % | -3.94 | |||||
| ROC (Joel Greenblatt) % | 61.17 | |||||
| ROCE % | 17.03 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 55.22 | |||||
| Forward PE Ratio | 50.21 | |||||
| PE Ratio without NRI | 55.22 | |||||
| Price-to-Owner-Earnings | 44.08 | |||||
| PEG Ratio | 6.73 | |||||
| PS Ratio | 6.38 | |||||
| PB Ratio | 7.07 | |||||
| Price-to-Tangible-Book | 23.43 | |||||
| Price-to-Free-Cash-Flow | 41.91 | |||||
| Price-to-Operating-Cash-Flow | 31.79 | |||||
| EV-to-EBIT | 36.19 | |||||
| EV-to-Forward-EBIT | 29.98 | |||||
| EV-to-EBITDA | 24.56 | |||||
| EV-to-Forward-EBITDA | 21.81 | |||||
| EV-to-Revenue | 6.17 | |||||
| EV-to-Forward-Revenue | 5.5 | |||||
| EV-to-FCF | 42.35 | |||||
| Price-to-GF-Value | 0.83 | |||||
| Price-to-Projected-FCF | 2.57 | |||||
| Price-to-Peter-Lynch-Fair-Value | 9.26 | |||||
| Price-to-Graham-Number | 7.57 | |||||
| Earnings Yield (Greenblatt) % | 2.76 | |||||
| FCF Yield % | 2.46 | |||||
| Forward Rate of Return (Yacktman) % | 10.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Metropolis Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 13,169.113 | ||
| EPS (TTM) (₹) | 29.58 | ||
| Beta | 1.18 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 23.77 | ||
| 14-Day RSI | 34.85 | ||
| 14-Day ATR (₹) | 59.694356 | ||
| 20-Day SMA (₹) | 1736.4925 | ||
| 12-1 Month Momentum % | 12.17 | ||
| 52-Week Range (₹) | 1551.05 - 2318.3 | ||
| Shares Outstanding (Mil) | 51.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Metropolis Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Metropolis Healthcare Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Metropolis Healthcare Ltd Frequently Asked Questions
What is Metropolis Healthcare Ltd(NSE:METROPOLIS)'s stock price today?
The current price of NSE:METROPOLIS is ₹1584.50. The 52 week high of NSE:METROPOLIS is ₹2318.30 and 52 week low is ₹1551.05.
When is next earnings date of Metropolis Healthcare Ltd(NSE:METROPOLIS)?
The next earnings date of Metropolis Healthcare Ltd(NSE:METROPOLIS) is 2025-05-21 Est..
Does Metropolis Healthcare Ltd(NSE:METROPOLIS) pay dividends? If so, how much?
Metropolis Healthcare Ltd(NSE:METROPOLIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers